A detailed history of Adar1 Capital Management, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 1,448,470 shares of BBIO stock, worth $40.2 Million. This represents 6.0% of its overall portfolio holdings.

Number of Shares
1,448,470
Previous 1,264,570 14.54%
Holding current value
$40.2 Million
Previous $32 Billion 15.13%
% of portfolio
6.0%
Previous 6.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$23.91 - $31.3 $4.4 Million - $5.76 Million
183,900 Added 14.54%
1,448,470 $36.9 Billion
Q2 2024

Aug 13, 2024

BUY
$23.0 - $31.04 $16.4 Million - $22.2 Million
714,766 Added 130.0%
1,264,570 $32 Billion
Q1 2024

May 15, 2024

BUY
$27.35 - $40.45 $9.97 Million - $14.8 Million
364,667 Added 196.97%
549,804 $17 Billion
Q4 2023

Feb 14, 2024

BUY
$24.02 - $43.89 $4.45 Million - $8.13 Million
185,137 New
185,137 $7.47 Billion

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $4.12B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.